Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.36 |
| ▸ | MELK | Q14680 | 1/20 | 0.36 |
| ▸ | STK24 | Q9Y6E0 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.36 |
| ▸ | AURKA | O14965 | 1/20 | 0.34 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.34 |
| ▸ | INCENP | Q9NQS7 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | PARP1 | P09874 | 3/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | AXL | P30530 | 1/20 | 0.32 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cytosine SCHEMBL4059 | 1.00 | — | — | |
| Cytosine SCHEMBL1330400 | 1.00 | — | — | |
| Cytosine SCHEMBL1330710 | 1.00 | — | — | |
| Cytosine SCHEMBL2406920 | 0.98 | — | — | |
| Cytosine SCHEMBL4065266 | 0.98 | — | — | |
| Cytosine SCHEMBL10623341 | 0.98 | — | — | |
| Cytosine SCHEMBL3678961 | 0.98 | — | — | |
| Cytosine SCHEMBL20212017 | 0.98 | — | — | |
| Cytosine SCHEMBL21772310 | 0.98 | DYRK1A (0.42) | DYRK1ATSHRJAK2RPS6KA3MELK | |
| Cytosine SCHEMBL4492966 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240229151-A9 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | HARBINGER HEALTH, INC. | 2024-07-11 | — | — | US | disclosed |
| CN-118098345-A | Chromosome aneuploidy detection method, device, equipment and storage medium | 深圳市真迈生物科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20240132970-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | FLAGSHIP PIONEERING INNOVATIONS VI LLC (US) | 2024-04-25 | — | — | US | disclosed |
| WO-2023147568-A2 | COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2023-08-03 | — | — | WO | disclosed |
| US-20230190709-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| CN-115340478-A | Schiff base ligand and preparation method and application of polynuclear rare earth complex thereof | 温州医科大学 | 2022-11-15 | — | — | CN | disclosed |
| CN-115266662-A | Hyperspectral sequencing method and system and gene sequencer | 深圳赛陆医疗科技有限公司 | 2022-11-01 | — | — | CN | disclosed |
| US-20190214145-A1 | Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen | KUREK ITZHAK (US) | 2019-07-11 | — | — | US | disclosed |
| EP-3186231-A1 | PROCESS FOR PRODUCING FLUOROCYTOSINE AND FLUOROCYTOSINE DERIVATIVES | University of Durham (GB) | 2017-07-05 | — | — | EP | disclosed |
| CN-104316621-B | Method for measuring total nucleotide in protein products | 上海征泰饲料有限公司 | 2017-01-11 | — | — | CN | disclosed |
| CN-104520437-B | A kind of chromosomal aneuploidy detection method and device | 深圳华大基因股份有限公司 | 2016-09-14 | — | — | CN | disclosed |
| WO-2016030662-A1 | PROCESS FOR PRODUCING FLUOROCYTOSINE AND FLUOROCYTOSINE DERIVATIVES | UNIVERSITY OF DURHAM (GB) | 2016-03-03 | — | — | WO | disclosed |
| CN-104043126-A | Modulation of axon degeneration | GENENTECH INC | 2014-09-17 | — | — | CN | disclosed |
| CN-102573855-A | Modulation of axonal degeneration | HOFFMANN LA ROCHE | 2012-07-11 | — | — | CN | disclosed |
| EP-1747276-B1 | CAROTENOID BIOSYNTHESIS INHIBITOR RESISTANCE GENES AND METHODS OF USE IN PLANTS | BASF PLANT SCIENCE GMBH (DE) | 2008-12-10 | — | — | EP | disclosed |
| EP-1747276-A2 | CAROTENOID BIOSYNTHESIS INHIBITOR RESISTANCE GENES AND METHODS OF USE IN PLANTS | BASF Plant Science GmbH (DE) | 2007-01-31 | — | — | EP | disclosed |
| WO-2005111218-A2 | CAROTENOID BIOSYNTHESIS INHIBITOR RESISTANCE GENES AND METHODS OF USE IN PLANTS | BASF PLANT SCIENCE GMBH (DE) | 2005-11-24 | — | — | WO | disclosed |
| EP-1005478-A1 | RIBONUCLEOSIDE-DERIVATIVE AND METHOD FOR PREPARING THE SAME | Pitsch, Stefan (CH) | 2000-06-07 | — | — | EP | disclosed |
| WO-1999009044-A1 | RIBONUCLEOSIDE-DERIVATIVE AND METHOD FOR PREPARING THE SAME | PITSCH STEFAN (CH) | 1999-02-25 | — | — | WO | disclosed |
| US-5698583-A | MIXING THE SOLUTION OF ATLEAST ONE OLIGOELEMENT, SELECTED FROM SODIUM SELENITE, MAGNESIUM /MANGANESE/AND ZINC CHLORIDE, COBALT, CERIUM, MOLYBDENUM AND SILICON WITH BUFFERED SOLUTION OF PHOSPHOLIPASE A2; USED FOR IMMUNOTHERAPY | CRESCENTI ERNESTO J V (AR) | 1997-12-16 | — | — | US | disclosed |